Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,266
  • Shares Outstanding, K 45,113
  • Annual Sales, $ 1,500 K
  • Annual Income, $ -9,780 K
  • 60-Month Beta 0.72
  • Price/Sales 11.55
  • Price/Cash Flow N/A
  • Price/Book 2.70
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +59.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3800 +3.45%
on 09/22/20
0.5350 -26.52%
on 09/01/20
-0.0305 (-7.20%)
since 08/24/20
3-Month
0.3800 +3.45%
on 09/22/20
0.6700 -41.33%
on 07/22/20
-0.0288 (-6.83%)
since 06/24/20
52-Week
0.2490 +57.87%
on 04/08/20
1.8400 -78.64%
on 10/07/19
-1.3569 (-77.54%)
since 09/24/19

Most Recent Stories

More News
Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS(TM)) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the publication of an important, peer-reviewed...

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the following...

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief Executive Officer and Appoints Blane Walter as Chairman of the Board of Directors

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Philippe Deschamps, has stepped down from...

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
Global Neurostimulation Devices Market: Analysis and Forecast, 2021-2030

, /PRNewswire/ -- Market Segmentation• By Product Type: Implantable and non-implantableImplantable neurostimulation devices can be further segmented into seven types - spinal cord stimulation, auditory...

ABT : 100.92 (-1.76%)
BSX : 37.12 (-1.59%)
HSDT : 0.3931 (-2.91%)
LIVN : 41.99 (+0.19%)
MDT : 101.27 (-1.66%)
NVRO : 138.51 (-1.88%)
NVTR : 0.13 (-23.17%)
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates

Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of 33.33% and 33.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the...

HSDT : 0.3931 (-2.91%)
Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended June...

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2020 financial...

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Helius Medical Technologies, Inc. (HSDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HSDT : 0.3931 (-2.91%)
Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS(TM) Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has submitted a request to the U.S....

HSDT : 0.3931 (-2.91%)
HSM.TO : 0.54 (+3.85%)
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breach of Fiduciary Duty Claims

Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Helius Medical Technologies, Inc. (NASDAQ: HSDT).

HSDT : 0.3931 (-2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade HSDT with:

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

2nd Resistance Point 0.4178
1st Resistance Point 0.4054
Last Price 0.3931
1st Support Level 0.3851
2nd Support Level 0.3772

See More

52-Week High 1.8400
Fibonacci 61.8% 1.2322
Fibonacci 50% 1.0445
Fibonacci 38.2% 0.8568
Last Price 0.3931
52-Week Low 0.2490

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar